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Abstract
Background: Annona stenophylla is a folk medicine popularly used in Zimbabwe for the treatment of  many ailments. This study 
was carried out to determine some of  the possible anti diabetic mechanisms of  its action using in vitro cell culturing methods.
Methods: A. stenophylla’s effects on glucose uptake were tested using muscle cells (C2Cl2). Expression of  glucose 4 transporters 
was determined by treating cell lines with plant extract. Total RNA was isolated and using RT-PCR, GLUT 4 expression levels 
were quantified. Translocation of  GLUT 4 was assessed using FITC fluorescence measured by flow cytometry. 
Results: Treatment of  cells with plant extract significantly increased glucose uptake in a concentration dependent manner, with 
the highest concentration (250 µg/ml) giving 28% increased uptake compared to the negative control. The increase in glucose 
uptake (2.5 times more than control) was coupled to increase in GLUT 4 mRNA and subsequently GLUT 4 translocation. Wort-
mannin expunged the A. stenophylla induced increase in GLUT 4 mRNA and glucose uptake. 
Conclusion: The results suggest that A. stenophylla aqueous extract increases glucose uptake partly through increasing the GLUT 
4 mRNA and translocation potentially acting via the PI-3-K pathway. This study confirms the ethnopharmacological uses of A. 
stenophylla indicating potential for anti-diabetic products formulation.
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The rapidly increasing incidence of  diabetes mellitus is 
becoming a serious threat to human health in all parts of  
the world. The control and treatment of  diabetes and its 
complications mainly depend on chemical or biochemi-
cal agents1. There is need for tight regulation of  glucose 
which is the main source of  energy for the body. After a 
meal insulin is released by the pancreatic islets inducing 
glucose uptake by tissues that are sensitive to it. Glucose 
transporter type 4 (GLUT4) is the major transporter in 
the GLUT family, that mediates glucose uptake by the 
muscle and adipose tissues2. Under insulin resistance, 
translocation of  insulin-sensitive GLUT4 is impaired, re-
sulting in the consequent defect in the insulin-stimulated 
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glucose uptake, a rate-limiting step for glucose dispos-
al3,4. In skeletal muscle, insulin stimulates glucose uptake 
primarily by increasing translocation and redistribution 
of  the GLUT4 from internal membrane to the plasma 
membrane5,6. The increased expression of  GLUT4 has 
previously been shown to lower blood glucose levels and 
enhance glucose transport and utilisation in skeletal mus-
cles7.
 
While conventional treatments such as sulfonylureas, 
metformin and thiazolidinediones are effective, they have 
several limitations, including adverse side effects, second-
ary failure or the inability to halt further loss of  insulin 
secretory capacity8 and in many cases the precise mecha-
nism of  action remains to be completely clarified9.
The insulin stimulation followed by cascade signalling 
enhances glucose uptake, utilisation and storage in vari-
ous tissues10. Therefore, muscle glucose-uptake and sup-
pression of  gluconeogenesis could be considered as an 
excellent target for treatment of  T2DM. Therapeutic ap-
proaches with natural products provide a fruitful source 
for searching safe, effective and relatively inexpensive 
new remedies for diabetes mellitus and associated meta-
bolic disorders3,11.
 
Annona stenophylla (family: Annonaceae), commonly 
known as the dwarf  custard apple, is a small rhizomatous 
shrub found in some regions of  Zimbabwe12. This plant 
has been used in traditional medicine and scientific stud-
ies have validated some of  the folkloric claims of  differ-
ent activities such as antiparasitic, anti-infective, antiviral 
and antidiabetic activities12,13,14. Earlier in our laboratory 
we have demonstrated that A. stenophylla plant extract 
possess antioxidant activity, antimicrobial activity and 
has potential hypoglycaemic effects. The hypoglycaemic 
activity has partly been attributed to its ability to inhibit 
carbohydrate metabolising enzymes and a polyherbal for-
mulation encoperating A. stenophylla has been formulat-
ed15,16,17,18,19. The extract has been found to be relatively 
safe to use through brineshrimp lethality tests and sub-
acute toxicity tests using a rat model20,21.
New insights into the mechanisms of  action in glucose 
lowering and insulin resistance may provide new treat-
ment strategies for diabetes. In a bid to explore the ob-
served effects of  A. stenophylla plant extract, mechanisms 
of  antidiabetic activity were investigated using established 
muscle cell lines.
Materials and methods
This was an experimental study performed at the Univer-
sity of  Zimbabwe, Physiology laboratory.
Reagents
Dulbecco’s Minimum Essential Medium DMEM, fetal 
bovine serum (FBS), trypsin-EDTA, antibiotic (strep/
penicillin) and Phosphate buffered saline (PBS) reagents 
were from Gibco, USA. Whatman No. 1 filter paper Merk 
(South Africa) Antibodies to GLUT4 were from Indaba 
Biotechnology (South Africa)
 
Plant material and extraction
The plant roots of  Annona stenophylla were collected 
from Mazowe District in Harare, Zimbabwe GPS coordi-
nates were latitude 17 ° 24 14.25 Southings and longitude 
30 ° 41  36.13  Eastings, using guidelines for sustainable 
harvesting of  traditional medicinal plants in Zimba-
bwe23,24. Identification and authentication was done with 
the aid of  a botanist from the National Herbarium and 
Botanic Gardens of  Zimbabwe, and a voucher specimen 
tagged (2540) was kept for reference. The roots were air 
dried for 4 weeks in the laboratory at ambient tempera-
ture, ground, and extracted overnight with distilled water 
at 37 °C. The filtered extract was lyophilized in a freeze 
dryer and stored at -20 °C until use.
Cell culture
C2Cl2 myocytes were maintained in Dulbecco’s Modi-
fied Eagles Medium (DMEM) supplemented with 10% 
Foetal Bovine Serum (FBS) and 1% antibiotic solution 
(10,000 U/ml penicillin G, 10 mg/ml streptomycin) in a 
humidified atmosphere of  air and 5% CO2 at 37
◦C1. The 
myocytes were left without change of  medium for 6-7 
days after seeding into 48 well plates for differentiation to 
occur and experiments were performed in the differenti-




The determination of  glucose uptake in C2Cl2 myotubes 
was performed using a modified method described pre-
viously25. Briefly, media was removed from cell wells and 
replaced with 1ml of  fresh medium containing increasing 
concentrations of  A. stenophylla aqueous extract, PBS as 
negative control and positive control insulin, followed by 
an overnight incubation period.  Glucose concentration 
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in the medium was determined after the incubation peri-
od by the glucose oxidase method using a commercial kit 
(KAT medicals) following the manufactures instructions. 
Test samples were tested in quadruplicates and repeated 
at a later occasion. Absorbances were read at 540nm in a 
microplate reader named (Anthos 2010). The amount of  
glucose taken up by the cells was regarded as being pro-
portional to the absorbance readings.  A standard curve 
using known glucose concentrations was constructed and 
used to extrapolate the glucose levels.
Extraction of  RNA and analysis of  gene expression
After exposure to plant or control treatments, total RNA 
was extracted from C2Cl2 myotubes (GeneJET RNA kit, 
Thermo Scientific). RNA was measured using a Qubit 
machine (Invitrogen) and normalised for cDNA synthe-
sis (Revert Aid 1st strand cDNA KIT, Thermo Scientif-
ic). RT-PCR was done using Thermo Scientific Dream 
Taq Green following manufacturer’s instructions. The 
PCR products were run on 1% agarose gels stained with 
ethidium bromide and quantified using ChemDoc Imag-
er software. GAPDH was used as an internal control.
The primers used were:
GAPDH: 5′-AACTTTGGCATTGTGGAAGG-3′ (for-
ward) and 5′-ACACATTGGGGGTAGGAACA-3’ (re-
verse)
Glut4: 5′-ACATACCTGACAGGGCAAGG-3′ (forward) 
and 5′-CGCCCTTAGTTGGTCAGAAG-3′ (reverse)
GLUT4 translocation
The levels of  GLUT 4 transporters in C2Cl2 myotubes 
(non permeabilised) were measured by flow cytometry. 
After cells were treated with plant extract or the controls, 
they were harvested and washed twice with 2% FBS in 
PBS. Cells were blocked using CD16/32 for 15 min and 
then incubated with a conjugated anti-GLUT4 antibody 
solution (1.0 µg/ml in PBS) for 1 h at 4 ◦C. Excess anti-
bodies after labelling were removed by washing twice in 
ice-cold PBS as described by Wang et al26. The cells on the 
surface membrane were measured in duplicate and assay 
repeated at a later occasion. The fraction of  GLUT 4 was 
expressed as increase in FITC fluorescence with respect 
to untreated stained cells.
Statistical analysis
Values are given as mean ± SE. Analysis of  statistical sig-
nificance of  differences in measurements between sam-
ples was done by one-way ANOVA followed by Dunnet’s 
post hoc test (GraphPad Prism version 5).  P < 0.05 was 
considered statistically significant.
Results
Effect of  A. stenophylla plant extract on glucose uptake 
in C2Cl2 cells
There was a general dose dependent increase in glucose 
uptake after 2 and 24 h of  both plant extract and insulin 
positive control administration (Figure 1).  Significant dif-
ferences in the 2h compared to 24h glucose uptakes were 
recorded for concentrations 125 µg/ml and 250 µg/ml (p 
= 0.011 and 0.014 respectively). A. stenophylla plant extract 
showed percentage increase in glucose uptake that was 
comparable to insulin (positive control).
Changes in glucose uptake were measured after 2h and 
24hours for the plant extract compared to the positive 
control insulin. % increase in glucose uptake was calcu-
lated as a fraction of  the untreated control. Each assay 
was done in triplicate (N=6) and repeated on a separate 
occasion and results are the average (± SD). * (P< 0.05) 
shows significant differences upon comparing 2 h per-
centage glucose uptakes to 24 h ones at a particular con-
centration.
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Effect of  A. stenophylla extract on GLUT4 mRNA lev-
els in C2Cl2 cells
Incubation of  C2Cl2 cells with A. stenophylla and insulin 
resulted in increased mRNA levels of  GLUT 4 when 
compared to the untreated control (Figure 2). The RT-
PCR products were approximately 150 bp.
cDNA prepared from total RNA was amplified using 
GLUT 4 primer after treatment with plant extract (250 
μg/mL) and insulin positive control (10 μM). Amplicon 
band sizes were equated to amounts of  mRNA levels of  
the GLUT 4. cDNA loading was normalised by use of  
the housekeeping gene (GAPDH). Results are the aver-
age (± SD) of  two assays (Each assay done in duplicate), 
N=4.
Figure 1: Effect of different treatments on glucose uptake in C2Cl2 muscle cells. 
Figure 2: Effect of A. stenophylla extract on GLUT 4 mRNA levels 
in C2Cl2 cells using RT-PCR.
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Equal amounts of  cDNA material loaded were shown by 
analysis of  the band sizes using Chemidoc Imager and 
this was confirmed by the almost equal amounts of  band 
intensities in GAPDH (Figure 3). The untreated control 
showed the least amount of  amplicon band intensities 
when compared to those from plant extract treated and 
insulin treated cells. Differences in band intensities were 
not significant when treated samples were compared to 
the untreated control (p>0.05)
GLUT 4 mRNA amplicons resulting from cells treated 
with plant extract compared to the positive control insu-
lin.   The amplicons’ differences in size were equated to 
differences in the mRNA levels of  GLUT 4 expressed. 
The housekeeping gene (GAPDH) primers were used to 
normalize the cDNA loaded. Results are the average (± 
SD) of  two assays (Each assay done in duplicate) N=4.
GLUT4 translocation measurement using flow cytometry
Thenumbers of  GLUT 4 on C2Cl2 myotubes plasma 
membrane surface were measured using flow cytome-
try.  The plant extract showed an increase in GLUT 4 cell 
surface transporters measured as 31.1± 11 MESF -FITC 
arbitrary units of  molecules of  equivalent soluble FITC 
fluorescence (figure 4). The untreated stained control had 
4.0 ± 0.46 MESF -FITC. As a percentage of  the untreat-
ed stained control the plant extract caused more increase 
in FITC levels compared to the positive control insulin. 
All the groups tested showed no significant differences 
of   levels of  surface GLUT 4 translocated to the surface 
membrane when compared amongst each other (p>0.14) 
in all cases. 
Figure 3: GLUT 4 mRNA amplicon intensities in C2Cl2 myotubes. 
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The numbers of  translocated GLUT 4 after treatment 
with plant and insulin standard control were quantified. 
Baseline fluorescence is shown in untreated stained cells 
(negative control). The intensities of  MESF-FITC were 
equated to amounts of  GLUT 4 translocated. Results are 
the average (± SD) of  three assays (Each assay done in 
duplicate), (N=6).
 
Effect of  wortmannin inhibitor on glucose uptake in 
C2Cl2 myotubes
Wortmannin inhibitor showed a decrease in the glucose 
uptake when administered to C2Cl2 cells over 24 h (Figure 
5). The 1.3 fold decrease in the glucose uptake was slight-
ly reversed to a 1.0 fold decrease when wortmannin was 
incubated together with 250 µg/ml of  plant extract.  The 
difference between the change in glucose uptake when 
treatment with inhibitor was compared to plant extract + 
inhibitor was, however, not significant (p = 0.264).
Effects of  treatment with wortmannin alone, plant ex-
tract + wortmannin and plant extract alone was measured 
after 24 hours. Results are the average (± SD) of  two 
assays done in duplicate (N=4).
Figure 4: The effect of A. stenophylla aqueous extract on GLUT4 
translocation in C2Cl2 myotubes. 
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Effect of  wortmannin on GLUT 4 mRNA levels in 
C2Cl2 muscle cells
Wortmannin treatment on C2Cl2 muscle cells decreased 
the levels of  GLUT 4 mRNA expressed (Figure 6) when 
compared to plant extract treatment alone and combined 
wortmannin and plant extract treatment.
Figure 5 : Effects of wortmannin on glucose uptake in C2Cl2 cells. 
Figure 6: RT-PCR showing effect of wortmannin on GLUT 4 
mRNA levels in C2Cl2 cells. 
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GLUT 4 primers were used to amplify the cDNA from 
cells treated with wortmannin compared to wortmannin 
+ plant extract and plant extract alone. Differences in 
amplicon band sizes were equated to differences in the 
expressed mRNA levels of  GLUT 4. Concentration of  
plant extract used was 250 µg/ml and wortmannin 1mM. 
Results are the average (± SD) of  two assays (Each assay 
done in duplicate), N=4.
The differences in amplicon band sizes were equated to 
differences in the expressed mRNA levels of  GLUT 4. 
Band densitometry analysis confirmed the decrease in 
GLUT 4 mRNA levels, using GAPDH as an internal 
control (Figure 7).
Band intensities of  the GLUT 4 amplicons resulting from 
cells treated with wortmannin compared to wortmannin 
+ plant extract and extract alone were measured. Differ-
ences in amplicon band sizes were equated to differences 
in themRNA levels of  GLUT 4 expressed. The house-
keeping gene (GAPDH) primers were used to normalize 
the cDNA loaded. Visual appreciation of  the differences 
in band densities is shown. Results are the average (± SD) 
of  two assays (Each assay done in duplicate) N=4.
Discussion
In previous studies the aqueous extract of  Annona steno-
phylla demonstrated hypoglycaemic and insulinotropic ef-
fects in alloxan-induced diabetic rats18.  Western diabetic 
drugs correct hypoglycemia by supplementing insulin, 
improving insulin sensitivity, increasing insulin secretion 
from the pancreas and/or glucose uptake by tissue cells27. 
Certain herbs may lower blood glucose28, however, their 
test results are subject to several factors and hence the 
present study was conducted to determine the potential 
mechanism of  action of  glucose-lowering effect shown 
by aqueous extract of  Annona senophylla.
Skeletal muscle is the principal site for postprandial glu-
cose utilization and a major element in the maintenance 
of  glucose homeostasis9,29. A wide array of  plant-derived 
molecules has been reported to be associated with bene-
ficial effects on glucose transport and metabolism in skel-
etal muscle cells1. In this study, plant extract treatment 
increased glucose uptake in a concentration-dependent 
manner which shows that the more concentrated the 
drug the more the effect. The effect of  extract treatment 
on GLUT 4 mRNA transcription was determined and 
proposed as a potential mechanism through which glu-
cose uptake was increased. Gel electrophoresis showed 
a visual appreciation of  how the different treatments af-
fected glucose uptake in the C2Cl2 myotubes. The least 
uptake was shown in the untreated cells and amplification 
shown would possibly be due to the basal mRNA avail-
able. Extract and insulin treatment did show an increase 
in the transcription of  GLUT 4 mRNA which would 
subsequently influence the amount of  glucose taken up 
by the cells (Figures 1 & 2). Translocation of  GLUT4 
to the cell surface could be a part of  the underlying mo-
lecular mechanism responsible for the insulin-mediated 
increased glucose transport30. In cell cultures the delivery 



















Figure 7: Band intensities of GLUT 4 mRNA levels in 
C2Cl2 myotubes treated with wortmannin. 
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sometimes is in animals. Increased glucose entry depends 
on amount of  GLUT 4 translocation and other facilita-
tive transporters. The differences in expression of  GLUT 
4 in cell line experiments can, therefore, be attributed to 
different treatment responses.
GLUT4 gene expression is also subject to up or down reg-
ulation depending on the physiologic state of  the organ-
ism. Changes in GLUT4 gene expression are observed in 
physiologic states of  altered glucose homeostasis30.  Fur-
ther to glucose uptake and mRNA assays, effect of  A. 
stenophylla extract on translocation of  GLUT 4 from the 
cytoplasm to the plasma membrane was assessed. GLUT 
4 is only transiently expressed at the plasma membrane 
of  cells and is endocytosed. The bound antibodies re-
main attached to the membrane, even during endocytosis, 
facilitating measurement of  the total fluorescence signal 
of  exposed GLUT 4 molecules31. The marginal increase 
in glucose uptake after treatment could be due to plants 
ability to enhance GLUT 4 translocation followed by in-
creased gene transcription and expression4. Although the 
difference in the effects of  untreated control compared 
to treatments were not significant, the influence of  the 
extract can be considered for use in combination with 
other allopathic drugs or herbal formulations like pro-
posed by Mohammad32.
Glucose uptake and GLUT 4 translocation has been 
shown to be mediated through two major pathways, in-
sulin-mediated PI3K pathway and insulin-independent 
AMPK pathway. Wortmannin, a drug which inhibits insu-
lin release and blocks many short term metabolic effects 
induced by insulin receptor activation, decreased glucose 
uptake in muscle cells. Decrease in glucose uptake was 
accompanied by decreased levels of  GLUT 4 mRNA 
levels. Wortmannin did not completely abolish gluco-
seuptake when incubated together with plant extract and 
this could be because A. stenophylla  plant extract partly 
reversed the inhibitory effect of  wortmannin. The role 
of  PI3K in A. stenophylla plant extract induced glucose 
uptake and increased mRNA levels affected by coincu-
bation with wortamannin suggest that uptake was partly 
PI3K dependent33.
Conclusion
The major goal in treating diabetes is to minimize eleva-
tion of  blood glucose without causing abnormally low 
levels of  blood glucose. The action mechanisms for hy-
poglycemic herbs are multiple and A. stenophylla extract 
stimulates glucose transport in C2Cl2 myotubes by en-
hancing GLUT4 translocation from the internal mem-
brane to plasma membrane accompanied with change in 
the total amount of  GLUT4 or its gene expression.
Our findings show that A. stenophylla appear to have the 
ability to modulate glucose metabolism and provide the 
molecular basis of  antihyperglycemic activity of  the ex-
tract, which can be a promising candidate for the man-
agement of  diabetes and associated metabolic disorders.
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